ロード中...
Buprenorphine Treatment for Opioid Use Disorder: An Overview
Opioid use disorder affects over 26 million individuals worldwide. There are currently three World Health Organization recommended and Food and Drug Administration (FDA) approved medication treatments for opioid use disorder: the full opioid agonist methadone, the opioid partial-agonist buprenorphin...
保存先:
出版年: | CNS Drugs |
---|---|
主要な著者: | , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
2019
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6585403/ https://ncbi.nlm.nih.gov/pubmed/31062259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-019-00637-z |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|